You are here: Industry Insights > Personalized

News List

Personalized Medicine Powered by AI: Tailored Treatments Based on Genetics Nurah Ekhlaque
July 24, 2025
Discover how AI is transforming personalized medicine by helping develop treatments tailored to an individual’s genetic profile. Explore its impact on drug discovery, patient care, and the future of pharma.
Personalized Vaccines: How Neoantigens Are Changing Cancer Immunotherapy Nurah Ekhlaque
April 07, 2025
Explore how neoantigen-based vaccines are revolutionizing cancer immunotherapy by enabling personalized, targeted treatment strategies for better outcomes.
Ethical and Regulatory Considerations in Personalized Medicine Saher Haider
April 07, 2025
Personalized medicine is revolutionizing healthcare by tailoring medical treatments to individual genetic profiles, lifestyles, and environmental factors.
Microbiome Impact on Drug Response and Personalized Medicine Nurah Ekhlaque
February 18, 2025
The gut microbiome impacts drug response and disease management. It affects drug metabolism, efficacy, and toxicity, and is crucial for personalized medicine.
Advancements in Personalized Medicine Research Saher Haider
February 05, 2024
Personalized Medicine, also known as Precision Medicine, Individualized Medicine.
Pharma Sources Insight January 2024: Pharmaceutical Industry in 2024 - Flexible Production, Innovative Drugs and Personalized Medicine Pharma Sources Insight
January 15, 2024
Pharmaceutical Industry Outlook in 2024.
Personalized Medicine: A New Era in Healthcare David Orchard-Webb
January 02, 2024
Personalized medicine, also known as precision or individualized medicine, is a rapidly evolving field where medical decisions are tailored to individual patients based on their genetic and genomic data.
Pharma and Health from Ingredients to Pills: 3D Printing for Personalized Medicine Lin Zhang
June 23, 2020
Personalized medicines are becoming more popular as they enable the use of patient’s unique characteristics which could play a vital role in the treatment of life-threatening diseases.
Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment PharmaSources.com
March 25, 2022
Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment.
With personalized medicine, a shelved cancer drug could get another shot WorldPharmaNews
February 09, 2022
A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer...